News & Articles

Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).

Guest editorial by Arindam Ghosh, MBBS, PhD, a physician-scientist by training with extensive experience in neurodegenerative and neuropsychiatric disorders, particularly Alzheimer’s disease and dementia

Guest editorial by Mark Holland, Ph.D. Director, Bioinformatics/Biostatistics for Chemistry and Immunoassay Research and Development, Beckman Coulter

Explore how CLINICAL24 Ambassador, Dr. Vasiliki E. Kalodimou, is leveraging flow cytometry to revolutionize treatments with stem cells and regenerative medicine

nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics

ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics

Guest editorial article by Vikas Singh, PhD, and Thomas Beadnell, PhD, from Eurofins

Researchers’ time is heavily taxed by admin and compliance workflows, but digital records and easy access to asset data can help

Amp-Seq One offers reduced hands-on time and doubled throughput

Roche’s Elecsys Amyloid Plasma Panel shows high accuracy in ruling out Alzheimer's, offering new hope for early and less invasive diagnostics

Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more

The EXENT System integrates immunoassay, MALDI-ToF mass spectrometry and intuitive data review software to provide enhanced analytical sensitivity and specificity for the measurement of monoclonal proteins

QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions